Advances in Diagnosis and Prognosis of Breast Cancer
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".
Deadline for manuscript submissions: 31 January 2025 | Viewed by 16
Special Issue Editor
Interests: genomics; cancer biomarkers; cancer biology; gene expression; tumor biology; chemotherapy; targeted therapy; metastasis
Special Issue Information
Dear Colleagues,
Breast cancer remains the most prevalent malignancy in women and its incidence continues to increase worldwide. In the last decade, meaningful insights into the biology of breast cancer have been achieved, and therefore significant advances in locoregional and systemic treatment have been made.
The latest diagnostic techniques include advanced imaging modalities such as MRI, PET-CT, and ultrasound-guided biopsy. In particular, there is a focus on the role of molecular biomarkers in early detection and personalized medicine. In addition, with the advent of genetic testing, our understanding of the risk of breast cancer has evolved significantly.
Exploring classical clinical–pathological and genomic prognostic parameters can more precisely facilitate in predicting the likelihood of distant disease recurrence and overall survival.
This Special Issue aims to enhance our knowledge regarding the latest advancements in the field of breast cancer diagnosis and prognosis. Original research articles, reviews and other papers are welcome. We look forward to receiving your valuable submissions.
Dr. Domen Ribnikar
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- breast cancer
- gene expression profiling in breast cancer
- cancer biomarkers
- tumor biology
- prediction
- prognosis
- systemic treatment
